| 今开：1.4 | 昨收：1.4 |
| 最高：1.4 | 最低：1.38 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：2.4125646E7 |
Exagen(XGN)02-10 06:15
$Exagen(XGN)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000814133-24-000052 Act: 34 Size: 4 KB 网页链接查看全文
Exagen(XGN)02-13 19:15
$Exagen(XGN)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-24-032792 Act: 34 Size: 128 KB 网页链接查看全文
Exagen(XGN)02-14 05:45
$Exagen(XGN)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000935836-24-000145 Act: 34 Size: 60 KB 网页链接查看全文
Exagen(XGN)02-15 03:45
$Exagen(XGN)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000935836-24-000187 Act: 34 Size: 30 KB 网页链接查看全文
Exagen(XGN)02-14 20:15
$Exagen(XGN)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000902664-24-001550 Act: 34 Size: 65 KB 网页链接查看全文
Exagen(XGN)03-05 05:15
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-24-000015 Size: 4 KB 网页链接查看全文
Exagen(XGN)03-18 21:35
$Exagen(XGN)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001274737-24-000022 Act: 34 Size: 9 MB 网页链接查看全文
Exagen(XGN)04-26 20:35
$Exagen(XGN)$ DEF 14A Other definitive proxy statements Accession Number: 0001274737-24-000028 Act: 34 Size: 1 MB 网页链接查看全文
Exagen(XGN)03-07 05:15
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-24-000017 Size: 6 KB 网页链接查看全文
Exagen(XGN)04-26 21:25
$Exagen(XGN)$ ARS Annual Report to Security Holders Accession Number: 0001274737-24-000037 Act: 34 Size: 13 MB 网页链接查看全文
蹊之美股生物医药2021-08-12 03:35
作者：林出
微信公众号：蹊之美股生物医药 / CaesarBiotech
Gainers:
Fulcrum Therapeutics (NASDAQ:FULC) +125%
Exagen (NASDAQ:XGN) +24%
Myomo (NYSE:MYO) +16%
IMV (NASDAQ:IMV) +8%
Allied Healthcare Products (NASDAQ:AHPI) +6%
Losers:...查看全文
$Exagen(XGN)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001274737-22-000065 Act: 33 Size: 592 KB 网页链接
$Exagen(XGN)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001274737-22-000064 Act: 34 Size: 545 KB 网页链接
$Exagen(XGN)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001274737-22-000052 Act: 34 Size: 6 MB 网页链接
$Exagen(XGN)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001274737-22-000051 Act: 34 Size: 307 KB 网页链接
$Exagen(XGN)$ 8-K Current report, item 5.07 Accession Number: 0001274737-22-000039 Act: 34 Size: 181 KB 网页链接
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-22-000040 Size: 5 KB 网页链接
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-22-000041 Size: 5 KB 网页链接
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-22-000042 Size: 5 KB 网页链接
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-22-000043 Size: 5 KB 网页链接
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-22-000044 Size: 5 KB 网页链接